Company

Company

We are on a mission to decode the immune system and improve health.

WHY US

We are a multidisciplinary team of immunologists, engineers, drug developers, computer scientists, and entrepreneurs focused on bringing breakthrough medicines to patients.

Built from the ground up with an engineering-first approach to biology and an unparalleled understanding of the immune system, we know we’re up for the challenge. Immunai was founded in December 2018. Our global team spans New York City, Tel Aviv, Prague, and Zurich.

In March 2021, Immunai acquired Dropprint Genomics, a Y-combinator backed, single cell genomics software company based in San Francisco. Dropprint’s database of immune cells further expanded AMICA.

In July 2021, Immunai made the transformational acquisition of NEBION, a world leader in biocuration and data integration. NEBION has structured hundreds of thousands of samples and millions of cells across thousands of public studies under a unified clinical ontology, all powered by bespoke expert curation. This data has supercharged AMICA’s growth and expanded our target discovery efforts into a wide range of inflammatory and oncological settings.

By the Numbers:

0 M

Funding

Leading investors including KDT and Alexandria Venture Investments

0

Founded

Read more about our Founding Story

0 +

Team members

Built from the ground up to balance scientific and tech resources. Includes 80+ PhDs.

0

Locations

HQ in NYC with offices in Tel Aviv, Prague and Zurich

0 +

Partnerships

With leading academic centers and biopharmaceutical companies

Our employees

Meet the team

Senior Leadership
Founding Team
Advisory Board

Noam Solomon, PhD

CEO & Co-Founder

Tali Raveh-Sadka, PhD

VP, Computational R&D

Sen Zhang

VP, Product

Adeeb Rahman, PhD

VP, Single Cell Immunology

Evan Zisholtz

VP, Corporate Development

Roy Cohen

VP, Finance

Elisha Nathan

VP, Strategic Alliances

Philip Zimmermann

VP, Business Development Europe

Galit Yahalom

VP, Operations

Ronit Weinstein

VP, Human Resources

Noam Solomon, PhD

CEO & Co-Founder

Luis Voloch

Co-Founder

Danny Wells, PhD

Scientific Co-Founder

Ansuman Satpathy, MD, PhD

Scientific Co-Founder

Dan Littman, MD, PhD

Scientific Co-Founder

Robert S. Langer, PhD

Mark Jacobstein

Regina Barzilay, PhD

Stanley Frankel, MD

Caroline Uhler, PhD

Rahul Satija, PhD

Tony Ho, MD

Prof. Ido Amit

Jimmie Ye, PhD

Life at Immunai

Work life

At Immunai, you’ll have an opportunity to work with great people, tackle massive challenges and make an impact on the health of patients worldwide.

Meena Subramaniam, PhD
Computation Biology Team Lead
“Immunai has allowed me to work alongside extremely talented individuals with diverse skill sets. Being able to tackle hard problems from multiple angles and with many tools as a team has been not only rewarding, but also a wonderful learning experience.”
Daniel Blinick
Software Engineer
“While the challenges at Immunai are both meaningful and stimulating, the pleasure of coming to work starts with the intelligent, spirited people I get to work with.”
Scott Gigante, PhD
Senior Machine Learning Engineer
“To me, working at Immunai is about constantly challenging myself — working with so many brilliant and motivated people pushes me to be the best I can be.”
Moran Elishmereni-Landau, PhD
Senior Scientific Project Manager
“For me, managing projects at Immunai is as stimulating as it is rewarding. There is a true sense of ownership and a spirit of collaboration, and I am lucky to work with an exceptional team of individuals with diverse backgrounds and experiences. We all come together to solve the most challenging problems in immunology and disease, and it’s a rush of creativity and adrenaline.”
Hadass Jessel, PhD
Scientific Product and Communications Designer
I joined Immunai because of the exciting technology, world class leadership, a drive to make better immune-based therapies and the opportunity to obtain a challenging role and within the fields of Science & Design. The team is truly exceptional and I believe we can accomplish anything we put our minds to.
Patrick Petrossian
Scientist, Molecular Profiling
“Immunai is driven by its company culture and the people that support it. I am surrounded by dedicated scientists who truly enjoy coming into work each day. You can’t help but feel drawn by Immunai’s exponential growth and want to help drive its success.”
Laura Polanco
Associate Scientist, Experimental Immunology
“At Immunai we are encouraged to explore and cultivate our scientific curiosity. I joined Immunai to learn from exceptional leaders in a highly collaborative environment. We apply our vast range of knowledge to creatively approach important issues in immunology for long term solutions.”
Amanda Robinson, PhD
Scientist, Experimental Immunology
“Joining Immunai was an exciting and unique opportunity for me because of their big data approach to drug discovery and development. We take on immunological and computational challenges everyday with creative multi-disciplinary solutions. I am grateful to work in a collaborative and inspiring environment where I can contribute to solving big problems and learn from my colleagues.”

Life at Immunai